SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-029539
Filing Date
2014-05-12
Accepted
2014-05-12 16:06:39
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v377177_10q.htm 10-Q 251986
2 EXHIBIT 31.1 v377177_ex31-1.htm EX-31.1 8146
3 EXHIBIT 31.2 v377177_ex31-2.htm EX-31.2 8410
4 EXHIBIT 32.1 v377177_ex32-1.htm EX-32.1 6109
  Complete submission text file 0001144204-14-029539.txt   3349629

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cpxx-20140331.xml EX-101.INS 470677
6 XBRL TAXONOMY EXTENSION SCHEMA cpxx-20140331.xsd EX-101.SCH 32020
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cpxx-20140331_cal.xml EX-101.CAL 45735
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cpxx-20140331_def.xml EX-101.DEF 174286
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cpxx-20140331_lab.xml EX-101.LAB 260572
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cpxx-20140331_pre.xml EX-101.PRE 212495
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36179 | Film No.: 14833465
SIC: 2834 Pharmaceutical Preparations